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【Abstract】

Background The prevalence of inflammatory bowel disease (IBD) increases annually in

China. The integrated traditional Chinese and western medicine is helpful to alleviate and control symptoms of IBD.
Quality of life (QoL) is an important index to evaluate the clinical efficacy of IBD. However, there are few studies
about IBD patient-reported outcomes (PROs) based on TCM theories. Objective

To determine the framework and

items, and then use them to develop the IBD PROs scale using TCM theories. Methods Under the guidance of the
TCM theory of “body and mind harmony, and man's adaptation to his total environment”, literature review, focus
group discussion and expert consultation were carried out. The conceptual framework and item pool of the draft of
an IBD PROs scale were developed, then the corresponding items were determined, forming the draft of the IBD
PROs scale. Then the draft scale was pre-tested in IBD patients treated in Department of Spleen and Stomach
Diseases, the First Affiliated Hospital of Guangzhou University of Chinese Medicine from January to June 2021.
Standard deviation, Cronbach's α and correlation analysis were used for item selection. Results The final IBD
PROs scale is composed of two domains: body and mind harmony (12 body-related items, and 9 mind-related items)
and man's adaptation to his total environment (6 items). Conclusion The IBD PROs scale which was developed
based on theories of TCM could be used to evaluate the QoL of IBD patients. But further clinical research is still
needed to verify its reliability and validity.
【Key words】 Inflammatory bowel disease；Patient-reported outcomes；TCM theories；Quality of life；Item
selection；Construction of scale
【Chinese Library Classification Number】 R 574 【Document Identification Code】 A

Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is a kind of intestinal
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disease with chronic non-specific inflammation of the intestinal mucosa as the main pathological change. Since 1990, the
incidence of IBD continued to rise in newly industrialized countries in Africa, Asia and South America, and IBD has become
a global disease [1]. The number of IBD cases in mainland China is on the rapid rise[2].
IBD is a chronic disease with low mortality. Compared with mortality, quality of life (QoL) is more suitable to be used as
an outcome indicator for clinical efficacy evaluation[3]. At present, two scales have been translated into Chinese: The 32-item
Inflammatory Bowel Disease Questionnaire (IBDQ-32)[4] (including the traditional Chinese version[5] and the simplified
Chinese version[6]) and the Short Health Scale (SHS)[7-8] . IBDQ-32 was the most widely used scale in China. Yang et al.[9]
developed a 56-item quality-of-life scale for ulcerative colitis with traditional Chinese medicine characteristics based on
Delphi method, and Ruan et al.[10] developed a 22-item IBD quality-of-life questionnaire (IBDQOL-22).
QoL measurement is affected by the social circumstances and cultural background of the subjects. The cultural
differences between the East and the West reduce the measurement performance of the scales[11]. The theories of traditional
Chinese medicine (TCM) which derived from the Huangdi Neijing, inherit the outstanding traditional culture of China. The
“harmonization between soma and spirit” and “correspondence between man and universe” are core ideas of TCM on health
[12-13]

. Chinese Quality of Life Instrument[14-15], Health Status Scale of Traditional Chinese Medicine[16] etc. which developed

on the basis of traditional Chinese medicine theories, have been testified to have good effectiveness of measurement and value
of use by clinical practices. Patient-reported outcomes (PROs) are any reports of a patient's health status that comes directly
from him or her without interpretation by the clinician or anyone else. PROs are recommended by the Food and Drug
Administration (FDA) of the United States as an effective tool to evaluate the benefits and risks of treatment in clinical
trials[17]. It is also recommended by the International Organization for the Study of IBD as one of the evaluation indicators for
treat-to-target strategies of patients with IBD[18]. However, there are few reports on IBD PROs scale developed based on
theories of traditional Chinese medicine. Therefore, this study developed an IBD PROs scale based on theories of traditional
Chinese medicine to provide an effective tool for clinical evaluation on TCM treatments of patients with IBD. The reliability
and validity of IBD PROs scale are still in progress. This article focuses on the framework construction and pre-test (item
selection) results of IBD PROs scale.
1 Materials and methods
1.1 Forming of the draft of IBD PROs scale
1.1.1 Literature research study “Inflammatory bowel disease, ulcerative colitis, Crohn's disease, quality of life” were used
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as keywords to search on the CNKI, and “inflammatory bowel disease, quality of life” to search on the PubMed, Embase for
retrieving articles on disease-specific scales of IBD, UC or CD. The search period was from the inception of the databases to
October 31th 2020. Inclusion criteria: (1) study objects: patients with establish diagnosis of IBD, UC and CD; (2) research
contents: development, translation or validation on reliability or validity of quality-of-life scales of IBD. Exclusion criteria: (1)
articles without full-text accessory or scale items; (2) articles on General QoL instruments. A total of 18 instruments for adults
with IBD were acquired, excluding the Quality-of-Life Index for Pediatric Inflammatory Bowel Disease (IMPACT)[30], the
IMPACT- Ⅱ[31] and the IMPACT- Ⅲ[32], 3 instruments of pediatric IBD. Details of these IBD disease-specific QoL instruments,
such as publication date, the first author, country, number of domains, number of items and number of items in each domain
etc. are shown in Table 1.
Table 1 IBD-specific health-related quality of life instruments
Abbreviation
of scale

Year of

First author

Nation Number Numbe

IBD-related

of

symptoms

publicatio
n

r of

Physical functioning

Emotional

Social functioning

or general wellbeing functioning

(Number of items)

domain items (Number of items) (Number of items)
s

IBDQ-32[4]

[19]

RFIPC

1989

1991

GUYATT

DROSSMAN

Canada

USA

4

4

(Number of
items)

32

25

a

Bowel symptoms

-

Emotional

(10), Systemic

functioning

symptoms (5)

(12)

Impact of disease

Body stigma (2),

(13),

Sexual intimacy (3)

Social function (5)

-

-

complications of
disease (4)
IBDQ-36[20]

1992

LOVE

Canada

5

36

Bowel symptoms

Functional

Emotional

Social function

(8), Systemic

impairment (7)

functioning (8)

impairment (6)

Medical/symptom

Affect/life in

-

Social

s (9)

general (11),

function/recreationa

Functional/economi

l (15)

symptoms (7)
CCQIBD

[21]

1992

FARMER

USA

4

47

c (12)
[22]

PIBDQL

1995

MARTIN

Italy

4

29

Bowel symptoms

-

(8), Systemic

Emotional

Social function (5)

functioning (9)

symptoms (7)
SIBDQ[23]

1996

IRVINE

Canada

4

10

Bowel symptoms

-

(3), Systemic

Emotional

Social function (2)

functioning (3)

symptoms (2)
[24]

CGQL

1999

FAZIO

USA

3

3

-

Quality of life (1),

-

-

quality of health (1),
physical activity
level (1)
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EIBDQ[25]

2002

SMITH

UK

3

13b

Bowel-specific

-

-

-

-

-

-

symptoms (6),
Disease-specific
symptoms (5)
IBDQ-9

[26]

2004

SHS[7]

2006

CUCQ[27]
QOLS of

ALCALÁ

Spain

1

9

HJORTSWAN Swede

4

4

G

n

2015

ALRUBAIY

UK

1

2015

Yang Ling

China

4

-

Symptom burden General wellbeing Disease-relate Social functioning
(1)

(1)

d worry (1)

(1)

8

-

-

-

-

56

-

Physical Factors

[9]

TCM for UC

(25), Overall

Psychological Independent factors
factors (9)

evaluation (2)
CLIQ[28]
IBDQOL-22

[10

(1), Social factors
(10)

2015

WILBURN

-

2

36

-

-

-

-

2017

RUAN

China

4

22

Bowel symptoms

-

Emotional

Social function (5)

]

and

function (6)

influences (6),
Symptoms and
discomfort (5)
[29]

PROBE

2019

THOMAS

USA

4

6

Bowel symptoms
(1), systemic

-

Emotional

Social functioning

functioning (2)

(2)

symptoms (1)
Notes:IBDQ-32: the 32-item Inflammatory Bowel Disease Questionnaire, RFIPC: the Rating Form of IBD Patient Concerns, IBDQ-36: the
3-item Inflammatory Bowel Disease Questionnaire, CCQIBD: the Cleveland Clinic Questionnaire for Inflammatory Bowel Disease, PIBDQL:
the Padova Inflammatory Bowel Disease Quality of Life, SIBDQ: the Short Inflammatory Bowel Disease Questionnaire, CGQL: the Cleveland
Global Quality of Life, EIBDQ: the Edinburgh Inflammatory Bowel Disease Questionnaire, IBDQ-9: the 9-item Inflammatory Bowel Disease
Questionnaire, SHS: the Short Health Scale, CUCQ: the Crohn’s and ulcerative colitis questionnaire, QOLS of TCM for UC: the Quality of Life
Scale of Traditional Chinese Medicine for Ulcerative Colitis, CLIQ: the Crohn’s Life Impact Questionnaire, IBDQOL-22: the 22-item IBD
Quality-of-life Questionnaire, PROBE: the PRO-based evaluation; a reprents 3 items can not be divided into these domains for low factor loading;
b

reprents 2 items of the EIBDQ on information can not be divided into these domains; -reprents content is missing.

1.1.2 Developing the Conceptual Framework

In accordance with the World Health Organization’s definition of QoL,

referencing to the international process and guidance of PROs instruments development, co-opted the conceptual framework
of the Spleen and Stomach disease PRO scale (SSDPRO) and the Myasthenia gravis-PRO scale (MG-PRO), “unity of body
and spirit” “correlation of five zang organs” “unity of nature and human” and “correlation of seven emotions”. Combined with
the TCM etiology and pathogenesis of IBD, the conceptual framework of the IBD PROs with TCM characteristics was
constructed.
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1.1.3

Generating item pool

To generate item pool, items of the internationally widely used IBD instruments were

referenced. Meanwhile, literatures on treating IBD with Chinese medicine or western medicine were retrieved from the
SinoMed, CNKI, Wangfang Data, VIP Chinese Journal Database, by using key words “IBD, UC, CD, treatment, syndrome
differentiation, symptom”. Search period was from the inception of the databases to October 31th 2020. Common subjective
symptoms or signs of patients with IBD, such as abdominal pain, diarrhea, tenesmus, fatigue, emaciation, sleeplessness etc.
were abstracted from these literatures.
1.1.4 Core-group discussion

Core-group was composed of 2 clinical experts of spleen and stomach diseases with associate

senior titles or above, 2 experts of scale development, and 4 undergraduate students of integrated traditional Chinese and
Western medicine from Guangzhou University of Chinese Medicine. Members of the core-group had a discussion on the
conceptual framework, item inclusion, and the clarity of the item semantics, based on the item pool generated from the
theories of Chinese medicine, the composition of QoL and literature research, combined with the theory of traditional Chinese
medicine and the clinical manifestations of IBD patients. The conceptual framework and items of the draft scale were
protocoled.
1.1.5 Experts consultation After the draft scale were protocoled, 2 senior TCM doctors with rich clinical experience
specialized in spleen and stomach diseases (one of them is an expert in TCM scale development) were consulted. The two
experts made language adjustments to the item stem and response options of the draft scale. The framework and items of the
draft scale were finally determined.
1.2 Pre-testing Patients with IBD who visited the Department of Spleen and Stomach Diseases of the First Affiliated
Hospital of Guangzhou University of Chinese Medicine from January to June 2021, were pre-tested using the drat scale.
Patients of this study were enrolled consecutively. Inclusion criteria: (1) In line with the diagnostic criteria of UC or CD in the
Chinese consensus on diagnosis and treatment of inflammatory bowel disease (Beijing, 2018)

[2]

; (2) Age between 16~75

years old; (3) Able to communicate normally, and to complete the questionnaires solely or with the assistance of others.
Exclusion criteria: With concurrent diseases, such as cancer or heart disease, which seriously affect QoL. A total of 113
questionnaires were distributed and all were recovered. One questionnaire with incomplete demographic data was excluded,
and 112 cases were finally included, including 72 males and 40 females; mean of age was (38.9±13.6) years; 69 cases were
patients with UC, and 43 cases were patients with CD.
1.3 Item selection
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1.3.1 Dispersion tendency analysis Dispersion tendency was measured by the standard deviation calculated by the score
of each item. Greater dispersion tendency represents better discriminant ability of the item. Standard deviation < 0.9 was
consider as the criterion for excluding item.
1.3.2 Cronbach's α coefficient The Cronbach's α coefficient of a domain was calculated, and the change of α coefficient
after retaining and deleting an item was compared. If the α coefficient increased significantly after deleting an item, the item
was deleted; otherwise, it was retained.
1.3.3

Correlation coefficient

The correlation coefficient between item and domain was evaluated by calculating the

correlation coefficient r of each item and domain score. The criterion for deleting item was r <0.5.
1.4 Statistical analysis

The SPSS 22.0 software was used for statistical analysis. Measurement data were expressed as

(x ̅±s), and count data were expressed as the number of cases. P<0.05 was considered statistically significant.
2 Results
2.1

The Draft IBD PROs Scale

The conceptual framework of the draft IBD PROs Scale includes 2 domains of

“harmonization between soma and spirit” and “correspondence between man and universe”, in which “harmonization
between soma and spirit” is composed of two aspects: “soma” and “spirit”. The “soma” aspect, based on the theory of
“correlation theory of Zang-fu vicera”, measures the symptoms of visceral systems related to the pathogenesis of IBD. The
“spirit” aspect measures the emotion and psychological states of patients with IBD from the perspective of joy, sorrow,
sadness, fear and so on. The “correspondence between man and universe” domain measures how disease affect the life, work
and interpersonal relationship of IBD patients. The draft scale included 28 items (Table 2). A 5-point Likert scale was used as
response options, including “very serious”, “heavy”, “moderate”, “mild” and “not at all”.
Table 2 Conceptual framework and items of the first draft of the IBD PROs
Domains
harmonization between

Aspects
soma

soma and spirit

Items
abdominal pain, diarrhea, abdominal distension, tenesmus（feeling of urgency to defecate, but with
incomplete defecation）, bloody stool, loss of appetite, nausea and vomiting, weight loss or
marasmus, malnutrition, fatigue and tired, palpitations（heatbeat gets louder）, decreased sexual
function

spirit

depression, upset, being annoyed, worry about the disease being passed on to future generations,
recurrent episodes of the disease, the damage of the disease, food aggravating the condition,
developing cancers, having surgery, being satisfied with the effectiveness of treatment

correspondence between

influence on the relationship with family, friends or colleagues, influence daily life, working

man and universe

capability, social activities, being a burden on others
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2.2 Result of item selection

The standard deviation of all 28 items were > 0.9, representing good dispersion tendency. As it

is shown in results, the Cronbach's α coefficient of the “soma” and the “spirit” aspects and the “correspondence between man
and universe” domain were 0.92, 0.92 and 0.89 respectively. The Cronbach's α coefficient of “spirit” aspect increased from
0.91 to 0.93 when item 22 was excluded. Except for the item 22 “Being satisfied with the effectiveness of treatment”, the
correlation coefficients of items and domains (aspects) scores and total scores were >0.50 (P<0.001). Details of the analysis
result for item selection are shown in Table 3. The IBD PROs scale was composed of two domains: “harmonization between
soma and spirit” and “correspondence between man and universe”. The “soma” aspect of the domain “harmonization between
soma and spirit” included 12 items, while the “spirit” aspect included 9. Domain “man's adaptation to his total environment”
contained 6 items.
Table 3 Item selection of the IBD PROs
Score
Domains/Aspects

（Mean±SD，
Points）

soma

r values (items and domains)
Cronbach's α
coefficient

correspondence
soma

spirit

between man and
universe

Total
scores

0.92
1. abdominal pain

3.63±0.96

0.91

0.71

0.54

0.50

0.66

2. diarrhea

3.34±1.23

0.91

0.76

0.61

0.59

0.73

3. abdominal distension

3.78±1.03

0.92

0.60

0.50

0.49

0.59

4. tenesmus

3.50±1.20

0.91

0.69

0.47

0.48

0.62

5. bloody stool

3.69±1.30

0.92

0.68

0.44

0.44

0.60

6. loss of appetite

3.98±1.14

0.91

0.79

0.47

0.59

0.69

7. nausea and vomiting

4.38±1.01

0.91

0.71

0.44

0.47

0.61

0.91

0.81

0.56

0.63

0.75

8. weight loss or
marasmus

3.52±1.34

9. malnutrition

3.46±1.31

0.91

0.84

0.62

0.66

0.79

10. fatigue and tired

3.32±1.20

0.91

0.77

0.55

0.68

0.74

11. flustered

3.83±1.13

0.91

0.70

0.53

0.54

0.66

0.92

0.65

0.55

0.48

0.63

12. decreased sexual
function

3.96±1.12

spirit

0.92
13. depression

3.59±1.13

0.91

0.74

0.80

0.69

0.82

14. upset

3.56±1.15

0.91

0.74

0.80

0.74

0.83

15. annoyed

3.43±1.15

0.91

0.74

0.80

0.74

0.84

0.92

0.48

0.71

0.50

0.62

16. worry about the
disease being passed on

2.94±1.30

to future generations
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17. worry about
recurrent episodes of

0.91

0.48

0.79

0.55

0.66

0.91

0.52

0.88

0.60

0.73

0.91

0.59

0.84

0.58

0.74

0.91

0.45

0.78

0.49

0.63

0.91

0.49

0.83

0.52

0.68

0.93

0.27

0.44

0.37

0.39

0.89

0.57

0.55

0.72

0.66

0.87

0.59

0.58

0.80

0.69

0.87

0.67

0.64

0.83

0.76

0.87

0.56

0.63

0.83

0.71

0.87

0.59

0.59

0.83

0.71

0.87

0.65

0.66

0.82

0.76

2.08±1.00

the disease
18. worry about the
damage of the disease

2.16±1.04

19. worry about food
aggravating the

2.45±1.18

condition
20. worry about

2.44±1.16

developing cancers
21. worry about having
surgery

2.31±1.18

22. being satisfied with
the effectiveness of

3.63±0.95

treatment
correspondence
between

man

0.89
and

universe
23.

influence

relationship with family
24.

influence

3.19±1.10

your

relationship

with

3.40±1.05

friends or colleagues
25. influence daily life
26. influence working
capability
27. influence social
activities
28. being a burden on
others

2.72±1.07
2.84±1.17

3.14±1.16

3.36±1.25

3 Discussion
With the rapid development of economy in China, the lifestyle and eating habits of Chinese residents are westernized
gradually, and the number of patients with IBD is increasing yearly. As a chronic disease, there is no radical cure for IBD in
western medicine. The goal of treatment is to alleviate symptoms, delay the progression of the disease and reduce
complications, improve the QoL of patients, and ultimately reduce medical costs[37]. Integrated traditional Chinese and
western medicine can help to induce deep remission and achieve treat-to-target, which can provide optimized treatments for
patients with IBD[38]. More and more TCM practitioners have carried out clinical trials of TCM or integrated Chinese and
Western medicine in the treatment of IBD. When searching for safe and effective treatments, attention should also be paid to
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the loss of QoL caused by IBD at the same time. To develop a suitable QoL measurement instrument based on China's national
conditions and the life experience and actual needs of Chinese IBD patients. Although the definition of QoL has never been
clearly proposed in TCM, the understanding of health implies the thinking of QoL in TCM. The scale established under the
guidance of theories of TCM can better reflect the expectations and habits of the domestic population[39].
The IBD PROs scale was developed based on the theories of TCM. It has the same theoretical basis with the SSDPRO
and the MG-PRO, so the conceptual framework is similar. The studies of the SSDPRO and the MG-PRO have confirmed that
the scale based on TCM theories can be used to measure QoL of Chinese patients. The IBD PROs includes two domains,
“harmonization between soma and spirit” and “correspondence between man and universe”. Domain “harmonization between
soma and spirit” is subdivided into two aspects: “soma” and “spirit”, corresponding to physiology and psychology
respectively. The conceptual framework of the IBD PROs conforms to the Biopsychosocial model and the WHO’s definition
of QoL. In order to ensure the representativity of the included items, the item pool was formed by referring to internationally
widely used IBD-specific instruments (including IBDQ-32, the short inflammatory bowel disease questionnaire, the SHS, the
RFIPC etc.) and combining the key points of IBD syndrome differentiation. After the discussion and language adjustment by
experienced TCM clinical experts of spleen and stomach disease and experts of scale development, a total of 27 items were
finally included through pre-testing, integrating dispersion tendency analysis, Cronbach's α coefficient and correlation
coefficient method to ensure the practicability of the items.
The IBD PROs included 27 items, and the number of items was reasonable. All the participants completed the
questionnaire within 10 minutes. Moreover, the IBD PROs is guided by the theories of TCM to construct the conceptual
framework and included items, with UC and CD patients enrolled. The IBD PROs may be more suitable to be used as an
outcome evaluation index for clinical research on IBD treatment with TCM when compared with the IBDQ-22.
The reliability, validity, and responsiveness of the IBD PROs have not been verified, which is the deficiency of this
study. Therefore, it is necessary to conduct field investigation and clinical validation with larger sample size to evaluate the
measurement performance of the IBD PROs, so as to further improve the IBD PROs. After the performance evaluation is
completed, the IBD PROs developed based on the theories of TCM can be used to measure the QoL of patients with IBD in
China, and can be used as the clinical effectiveness evaluation of IBD, especially the outcome evaluation index of clinical
studies of TCM in the treatment of IBD.
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